// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Impact of ceftriaxone monotherapy for gonorrhoea diagnosed at point-of-care: missed opportunity to treat concomitant chlamydia?

Sophie Dunin De Skrzynno - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

ceftriaxone

The predictive value of symptoms and investigations in the diagnosis of neurosyphilis

Fareed Shiva - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Reagin

Mycoplasma genitalium - correlating guidelines with clinical care

Shingisai Ndoro - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Neisseria gonorrhoeae: efficacy of empirical treatment and review of local trends in antibiotic susceptibility - what’s occurring?

Paul McMullen - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Management of gonorrhoea and resistance patterns in a large integrated sexual health service

Yiwen Soo - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A review of syphilis diagnoses in a semirural setting

Hayley Hamlett - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Clinical evaluation of the SpeeDx CT-LGV (Beta): a new multiplex real-time PCR for simultaneous detection of Chlamydia trachomatis and invasive serovars causing lymphogranuloma venereum (LGV)

Jyotsna Dupaguntla - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The truth lies in the eye of the beholder: Neisseria gonorrhoeae

Razan Saman - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Hydroxyzine

Ocular symptoms as atypical presentation of re-emerging pathogen

Brian McCann - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The association of chemsex with the diagnoses of syphilis, gonorrhoea, and chlamydia among men who have sex with men in the UK

Louis MacGregor - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Evolving trends in sexual behaviours, clinic attendance patterns and diagnoses of sexually transmitted infections from 2016–2019: a perspective from Bristol

Louis MacGregor - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Examining ethnic differences in the incidence and predictors of STI diagnoses; findings from a longitudinal study of sexual health clinic (SHC) attendees in England

Megan Bardsley - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Safely expanding online chlamydia treatment during the COVID-19 pandemic

Jennifer Taylor - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Explorative data analysis of new cases of Syphilis in a rural population over a 6 year period

Imogen Ross - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Are online pharmacies who provide chlamydia treatment meeting BASHH standards, including the provision of accurate and relevant health advice and risk reduction strategies?

Jonathan Shaw - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Is there an association between intensive STI screening and gonococcal AMR in MSM? An analysis of national surveillance data in England, 2015–2018

Hester Allen - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Azithromycin

An opportunistic review of TV NAAT testing in men

Sophie Brady - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

‘Rolling’ audit of the management of gonorrhoea across a multi-hub sexual health service

Sophia Davies - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The economic burden of gonorrhoea in England: testing, treatment and sequelae

Anja Anderson - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Environmental contamination by Chlamydia trachomatis and Neisseria gonorrhoeae: is it time to change our cleaning regimes?

Katie Ovens - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved